WEBULL
News
ICLR
154.57
+2.64%
3.98
Weekly Report: what happened at ICLR last week (0202-0206)?
Weekly Report · 1d ago
Is ICON (ICLR) Quietly Redefining Its Oncology Moat With the Brian Moran Institute Expansion?
Simply Wall St · 3d ago
It's Down 28% But ICON Public Limited Company (NASDAQ:ICLR) Could Be Riskier Than It Looks
Simply Wall St · 4d ago
IQVIA slides after Q4 results as earnings outlook underwhelms
Seeking Alpha · 4d ago
Weekly Report: what happened at ICLR last week (0126-0130)?
Weekly Report · 02/02 09:07
ICON plc Expands Oncology Research Network With New Illinois Cancer Institute
Reuters · 01/27 17:02
ICON’s Accellacare Site Network Expands Oncology Research Capabilities With New Cancer Institute Partnership
Barchart · 01/27 06:15
GreensKeeper Value Fund Q4 2025 Portfolio Update: Long-Term Winners
Seeking Alpha · 01/27 03:30
Weekly Report: what happened at ICLR last week (0119-0123)?
Weekly Report · 01/26 09:07
Icon Is Maintained at Hold by TD Cowen
Dow Jones · 01/22 17:03
TD Cowen Maintains Hold on Icon, Raises Price Target to $183
Benzinga · 01/22 16:53
Polen Global Growth Portfolio adds to Taiwan Semiconductor, trims stake in Oracle in Q4 2025
Seeking Alpha · 01/22 16:32
Icon price target raised to $183 from $172 at TD Cowen
TipRanks · 01/22 14:30
Assessing ICON (ICLR) Valuation After Muted Share Performance And Mixed Pricing Signals
Simply Wall St · 01/22 05:32
Weekly Report: what happened at ICLR last week (0112-0116)?
Weekly Report · 01/19 09:08
Is ICON (ICLR) Price Weakness Creating A Long Term Opportunity For Investors
Simply Wall St · 01/17 04:32
ICON’s Role in Zealand Pharma’s Petrelintide Kidney Study: What Trial Completion Means for Investors
TipRanks · 01/15 16:30
Does ICON (ICLR) Face a Deeper Credibility Test as Disclosure Risks Draw Fresh Scrutiny?
Simply Wall St · 01/14 14:21
Weekly Report: what happened at ICLR last week (0105-0109)?
Weekly Report · 01/12 09:08
A Look At ICON (ICLR) Valuation After Revenue Shortfall Disclosure And Securities Class Action Deadline News
Simply Wall St · 01/12 08:18
More
Webull provides a variety of real-time ICLR stock news. You can receive the latest news about ICON PLC through multiple platforms. This information may help you make smarter investment decisions.
About ICLR
ICON Public Limited Company is a healthcare intelligence and clinical research organization. The Company is engaged in providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. It offers a range of specialized services to assist pharmaceutical, biotechnology and medical device companies to bring new drugs and devices to market faster. The Company's services include clinical research services, commercial positioning, consulting, early phase, strategic solutions, laboratories, language services, medical imaging, real world intelligence, site and patient solutions, COVID-19 clinical operation and decentralized and hybrid clinical solutions. It also provides its full range of clinical, consulting and commercial services across several sectors, which include biosimilars, biotechnology, government and public health solutions, medical devices and pharmaceuticals.